Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
53
BILI Quote, Financials, Valuation and Earnings
Last price:
$18.27
Seasonality move
:
1.25%
Day range:
$17.81 - $18.36
52-week range:
$12.72 - $31.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.92x
P/B ratio:
3.74x
Volume:
4.4M
Avg. volume:
3.7M
1-year change:
22.45%
Market cap:
$7.4B
Revenue:
$3.7B
EPS (TTM):
-$0.20
Earnings Data
Next earnings date for BILI
Aug 22
2025
Most recent earnings per share
-$0.00
Missed by $0.08
(May 20/2025)
Consensus Estimate
$0.07
(May 20/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BILI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/22/2025 | Q2 | $1B | -- | -- | $0.17 | -- |
| 05/20/2025 | Q1 | $958.7M | $962.7M | -$0.00 | $0.07 | -$0.08 |
| 02/20/2025 | Q4 | $1B | $1.1B | $0.03 | $0.14 | -$0.11 |
| 11/14/2024 | Q3 | $995.1M | $1B | -$0.03 | $0.08 | -$0.11 |
| 08/22/2024 | Q2 | $847.9M | $851.9M | -$0.20 | -$0.10 | -$0.10 |
| 05/23/2024 | Q1 | $780.1M | $791.7M | -$0.25 | -$0.17 | -$0.08 |
| 03/07/2024 | Q4 | $877.5M | $882.1M | -$0.43 | -$0.22 | -$0.21 |
| 11/29/2023 | Q3 | -- | -- | -$0.45 | -$0.26 | -$0.19 |
| 08/17/2023 | Q2 | -- | -- | -$0.54 | -$0.36 | -$0.18 |
| 06/01/2023 | Q1 | -- | -- | -$0.22 | -$0.42 | $0.20 |
| 03/02/2023 | Q4 | -- | -- | -$0.53 | -$0.51 | -$0.02 |
| 11/29/2022 | Q3 | -- | -- | -$0.63 | -$0.67 | $0.04 |
| 09/08/2022 | Q2 | -- | -- | -$0.77 | -$0.63 | -$0.13 |
| 06/09/2022 | Q1 | -- | -- | -$0.91 | -$0.62 | -$0.29 |
| 03/03/2022 | Q4 | -- | -- | -$0.83 | -$0.67 | -$0.16 |
| 11/17/2021 | Q3 | -- | -- | -$1.09 | -$0.67 | -$0.42 |
| 08/19/2021 | Q2 | -- | -- | -$0.45 | -$0.45 | -$0.00 |
| 05/13/2021 | Q1 | -- | -- | -$0.39 | -$0.34 | -$0.05 |
| 02/24/2021 | Q4 | -- | -- | -$0.35 | -$0.33 | -$0.03 |
| 11/18/2020 | Q3 | -- | -- | -$0.44 | -$0.39 | -$0.05 |
| 08/26/2020 | Q2 | -- | -- | -$0.23 | -$0.22 | -$0.01 |
| 05/18/2020 | Q1 | -- | -- | -$0.23 | -$0.14 | -$0.09 |
| 03/17/2020 | Q4 | -- | -- | -$0.17 | -$0.14 | -$0.02 |
| 11/18/2019 | Q3 | -- | -- | -$0.18 | -$0.15 | -$0.02 |
| 08/26/2019 | Q2 | -- | -- | -- | -$0.12 | -- |
| 05/13/2019 | Q1 | -- | -- | -- | -$0.13 | -- |
| 02/27/2019 | Q4 | -- | -- | -- | -$0.10 | -- |
| 11/20/2018 | Q3 | -- | -- | -- | -$0.08 | -- |
| 08/27/2018 | Q2 | -- | -- | -- | -$0.02 | -- |
| 05/23/2018 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
Bilibili Earnings Questions
-
How Much did Bilibili Generate in Revenue Last Quarter?
Bilibili reported $962.7M worth of top line sales in its most recent quarter.
-
Did Bilibili Beat Earnings Last Quarter?
Bilibili announced earnings per share of -$0.00 which represents a miss of analyst forecast a $0.07 per share.
-
Is Bilibili Profitable?
Bilibili reported $349M that represents $0.83 per share over the last quarter.
-
What is the Analyst Consensus for Bilibili EPS Next Year?
Bilibili's earnings are forecast to decrease from -$0.45 per share to -$0.02 per share next year representing a decrease of -98.5%.
-
When is Bilibili's Earnings Date?
Bilibili's next earnings date is August 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
